aluminum has been researched along with Grippe in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fodor, K; Gonczol, E; Jankovics, I; Jankovics, M; Kis, Z; Kuti, D; Pallinger, E; Sarkadi, J; Visontai, I | 1 |
| Chen, CH; Fang, CT; Lin, YJ; Shih, YJ | 1 |
| Balaton, G; Kalabay, L; Rozsa, N; Torzsa, P; Vajo, P; Vajo, Z | 1 |
| Basser, RL; Bennet, J; Formica, NT; Hartel, G; Höschler, K; McVernon, J; Nolan, T; Richmond, PC; Ryan, D; Sawlwin, DC; Skeljo, MV; Stoney, T; Zambon, MC | 1 |
| Engelmann, H; Hehme, N; Kuenzel, W; Neumeier, E; Saenger, R | 1 |
| Yokoi, T | 1 |
1 review(s) available for aluminum and Grippe
| Article | Year |
|---|---|
Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis.
Topics: Adjuvants, Immunologic; Aluminum; Antibodies, Neutralizing; Bias; Hemagglutination Inhibition Tests; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Salts | 2018 |
3 trial(s) available for aluminum and Grippe
| Article | Year |
|---|---|
Licensing the first reduced, 6 µg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aluminum; Antibodies, Viral; Dosage Forms; Double-Blind Method; Female; Hemagglutination Inhibition Tests; Humans; Immunogenicity, Vaccine; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Licensure; Male; Middle Aged; Prospective Studies; Vaccination; Virion; Young Adult | 2019 |
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
Topics: Adjuvants, Immunologic; Aluminum; Antibodies, Viral; Child; Child, Preschool; Double-Blind Method; Female; Hemagglutination Inhibition Tests; Humans; Infant; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neutralization Tests; Treatment Outcome | 2008 |
Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum; Antibodies, Viral; Hemagglutination Inhibition Tests; Humans; Immunoglobulin A; Influenza A virus; Influenza Vaccines; Influenza, Human; Neuraminidase; Neutralization Tests | 2004 |
2 other study(ies) available for aluminum and Grippe
| Article | Year |
|---|---|
Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Aluminum; Animals; Antibodies, Viral; Chickens; Female; Granzymes; Hemagglutination Tests; Humans; Immune Sera; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Neuraminidase; Neutralization Tests; RNA, Messenger | 2017 |
[Studies on prophylactic effects of the aluminum adjuvant influenza virus hemagglutinin (HA) vaccine (author's transl)].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum; Evaluation Studies as Topic; Hemagglutinins, Viral; Humans; Influenza Vaccines; Influenza, Human | 1979 |